127 related articles for article (PubMed ID: 15785824)
1. Comments on the paper "c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors".
Metze K; Adam RL
Braz J Med Biol Res; 2005 Feb; 38(2):141-3; discussion 144-5. PubMed ID: 15785824
[No Abstract] [Full Text] [Related]
2. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
Dutra AP; Granja NV; Schmitt FC; Cassali GD
Braz J Med Biol Res; 2004 Nov; 37(11):1673-81. PubMed ID: 15517084
[TBL] [Abstract][Full Text] [Related]
3. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
4. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
5. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
6. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
7. Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.
Tanaka T; Shimada T; Akiyoshi H; Shimizu J; Zheng C; Yijyun L; Mie K; Hayashi A; Kuwamura M; Hoshi F; Ohashi F
J Vet Med Sci; 2013 Oct; 75(10):1393-8. PubMed ID: 23728200
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
9. In pursuit of a prognostic marker in canine mammary tumors.
Miller MA; Mohammed SI
Vet J; 2011 Sep; 189(3):245. PubMed ID: 21277242
[No Abstract] [Full Text] [Related]
10. Results of hyperamplification of centrosomes in naturally developing tumors of dogs.
Setoguchi A; Okuda M; Nishida E; Yazawa M; Ishizaka T; Hong SH; Hisasue M; Nishimura R; Sasaki N; Yoshikawa Y; Masuda K; Ohno K; Tsujimoto H
Am J Vet Res; 2001 Jul; 62(7):1134-41. PubMed ID: 11453492
[TBL] [Abstract][Full Text] [Related]
11. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
12. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog.
Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M
Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989
[TBL] [Abstract][Full Text] [Related]
16. Trisomy 1 in a canine mammary tubular adenocarcinoma, complex type.
Mayr B; Eschborn U; Loupal G; Schleger W
Vet Pathol; 1993 May; 30(3):311-3. PubMed ID: 8333114
[No Abstract] [Full Text] [Related]
17. Identification of genetic variation in 11 candidate genes of canine mammary tumour.
Borge KS; Børresen-Dale AL; Lingaas F
Vet Comp Oncol; 2011 Dec; 9(4):241-50. PubMed ID: 22077404
[TBL] [Abstract][Full Text] [Related]
18. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HOX gene expression in canine mammary tumour cell lines from spontaneous tumours.
DeInnocentes P; Perry AL; Graff EC; Lutful Kabir FM; Curtis Bird R
Vet Comp Oncol; 2015 Sep; 13(3):322-36. PubMed ID: 24034269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]